Masoud Maher's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Jun 10, 2024
- Accession no.
- 0001415889-24-016259
- Filed
- Jun 10, 2024
- Trade date
- Jun 7-10, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $489.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Masoud MaherCIK 0001874571 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Common Stock | PPurchaseAcquired | +29,557 | $4.87 | +$143,942.59 | 29,557 | Direct | |
| Jun 10, 2024 | Common Stock | PPurchaseAcquired | +70,443 | $4.90 | +$345,170.7 | 100,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.